{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:46:47Z","timestamp":1781794007498,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1124\/molpharm.121.000478","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T15:38:58Z","timestamp":1653320338000},"page":"17-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Discovery of Novel Activators of Large-Conductance Calcium-Activated Potassium Channels for the Treatment of Cerebellar Ataxia"],"prefix":"10.1016","volume":"102","author":[{"given":"Sharan R.","family":"Srinivasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chih","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Nasburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai M.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Strassmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Wulff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram G.","family":"Shakkottai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/molpharm.121.000478_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-5793(00)01584-2","article-title":"hKCNMB3 and hKCNMB4, cloning and characterization of two members of the large-conductance calcium-activated potassium channel \u03b2 subunit family","volume":"474","author":"Behrens","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1124\/molpharm.121.000478_bib2","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1074\/jbc.275.9.6453","article-title":"Cloning and functional characterization of novel large conductance calcium-activated potassium channel \u03b2 subunits, hKCNMB3 and hKCNMB4","volume":"275","author":"Brenner","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.121.000478_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/acn3.527","article-title":"Targeting potassium channels to treat cerebellar ataxia","volume":"5","author":"Bushart","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1124\/molpharm.121.000478_bib4","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/mds.28355","article-title":"A chlorzoxazone-baclofen combination improves cerebellar impairment in spinocerebellar ataxia type 1","volume":"36","author":"Bushart","year":"2021","journal-title":"Mov Disord"},{"key":"10.1124\/molpharm.121.000478_bib6454421","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1126\/science.7687074","article-title":"mSlo, a complex mouse gene encoding \"maxi\" calcium-activated potassium channels","volume":"261","author":"Butler","year":"1993","journal-title":"Science"},{"key":"10.1124\/molpharm.121.000478_bib5","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/brain\/awy145","article-title":"De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene","volume":"141","author":"Chemin","year":"2018","journal-title":"Brain"},{"key":"10.1124\/molpharm.121.000478_bib6","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1093\/hmg\/ddaa212","article-title":"Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1","volume":"29","author":"Chopra","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1124\/molpharm.121.000478_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198040","article-title":"Dendritic potassium channel dysfunction may contribute to dendrite degeneration in spinocerebellar ataxia type 1","volume":"13","author":"Chopra","year":"2018","journal-title":"PLoS One"},{"key":"10.1124\/molpharm.121.000478_bib8","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1093\/hmg\/ddx281","article-title":"Potassium channel dysfunction underlies Purkinje neuron spiking abnormalities in spinocerebellar ataxia type 2","volume":"26","author":"Dell\u2019Orco","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1124\/molpharm.121.000478_bib9","doi-asserted-by":"crossref","first-page":"11292","DOI":"10.1523\/JNEUROSCI.1357-15.2015","article-title":"Neuronal atrophy early in degenerative ataxia is a compensatory mechanism to regulate membrane excitability","volume":"35","author":"Dell\u2019Orco","year":"2015","journal-title":"J Neurosci"},{"key":"10.1124\/molpharm.121.000478_bib10","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(10)70183-6","article-title":"Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond","volume":"9","author":"Durr","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1124\/molpharm.121.000478_bib11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/86546","article-title":"Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels","volume":"7","author":"Gribkoff","year":"2001","journal-title":"Nat Med"},{"key":"10.1124\/molpharm.121.000478_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.683769","article-title":"BK channel-mediated microglial phagocytosis alleviates neurological deficit after ischemic stroke","volume":"15","author":"Huang","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/molpharm.121.000478_bib13","doi-asserted-by":"crossref","first-page":"29489","DOI":"10.1038\/srep29489","article-title":"4-Aminopyridine reverses ataxia and cerebellar firing deficiency in a mouse model of spinocerebellar ataxia type 6","volume":"6","author":"Jayabal","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/molpharm.121.000478_bib14","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.chembiol.2012.07.013","article-title":"Selective positive modulator of calcium-activated potassium channels exerts beneficial effects in a mouse model of spinocerebellar ataxia type 2","volume":"19","author":"Kasumu","year":"2012","journal-title":"Chem Biol"},{"key":"10.1124\/molpharm.121.000478_bib794515","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0898-6568(94)90019-1","article-title":"Pharmacology and structure of high conductance calcium-activated potassium channels","volume":"6","author":"Knaus","year":"1994","journal-title":"Cellular Signalling"},{"key":"10.1124\/molpharm.121.000478_bib15","doi-asserted-by":"crossref","first-page":"A540","DOI":"10.1096\/fasebj.21.5.A540-c","article-title":"SK channels modulate firing frequency, calcium influx, and stress-induced catecholamine secretion in mice","volume":"21","author":"Kolski-Andreaco","year":"2007","journal-title":"FASEB J"},{"key":"10.1124\/molpharm.121.000478_bib16","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1093\/hmg\/ddz117","article-title":"De novo loss-of-function KCNMA1 variants are associated with a new multiple malformation syndrome and a broad spectrum of developmental and neurological phenotypes","volume":"28","author":"Liang","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1124\/molpharm.121.000478_bib17","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1073\/pnas.100118597","article-title":"A neuronal beta subunit (KCNMB4) makes the large conductance, voltage- and Ca2+-activated K+ channel resistant to charybdotoxin and iberiotoxin","volume":"97","author":"Meera","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.121.000478_bib18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/19336950.2021.1938852","article-title":"An emerging spectrum of variants and clinical features in KCNMA1-linked channelopathy","volume":"15","author":"Miller","year":"2021","journal-title":"Channels (Austin)"},{"key":"10.1124\/molpharm.121.000478_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-2999(94)90442-1","article-title":"Selective activation of Ca2+ -dependent K+ channels by novel benzimidazolone","volume":"251","author":"Olesen","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/molpharm.121.000478_bib20","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1523\/JNEUROSCI.19-05-01663.1999","article-title":"Ionic currents underlying spontaneous action potentials in isolated cerebellar Purkinje neurons","volume":"19","author":"Raman","year":"1999","journal-title":"J Neurosci"},{"key":"10.1124\/molpharm.121.000478_bib21","doi-asserted-by":"crossref","first-page":"9474","DOI":"10.1073\/pnas.0401702101","article-title":"Cerebellar ataxia and Purkinje cell dysfunction caused by Ca2+-activated K+ channel deficiency","volume":"101","author":"Sausbier","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.121.000478_bib22","doi-asserted-by":"crossref","first-page":"13002","DOI":"10.1523\/JNEUROSCI.2789-11.2011","article-title":"Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3","volume":"31","author":"Shakkottai","year":"2011","journal-title":"J Neurosci"},{"key":"10.1124\/molpharm.121.000478_bib23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ncl.2013.04.006","article-title":"Clinical neurogenetics: autosomal dominant spinocerebellar ataxia","volume":"31","author":"Shakkottai","year":"2013","journal-title":"Neurol Clin"},{"key":"10.1124\/molpharm.121.000478_bib24","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.neuron.2019.11.019","article-title":"Nicotinamide pathway-dependent Sirt1 activation restores calcium homeostasis to achieve neuroprotection in spinocerebellar ataxia type 7","volume":"105","author":"Stoyas","year":"2019","journal-title":"Neuron"},{"key":"10.1124\/molpharm.121.000478_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbamem.2004.07.006","article-title":"Activation of human IK and SK Ca2+-activated K+ channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime)","volume":"1665","author":"Str\u00f8b\u00e6k","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/molpharm.121.000478_bib26","doi-asserted-by":"crossref","first-page":"9200","DOI":"10.1073\/pnas.93.17.9200","article-title":"Cloning, expression, and distribution of a Ca(2+)-activated K+ channel beta-subunit from human brain","volume":"93","author":"Tseng-Crank","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.121.000478_bib27","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1523\/JNEUROSCI.0380-04.2004","article-title":"SKCa channels mediate the medium but not the slow calcium-activated afterhyperpolarization in cortical neurons","volume":"24","author":"Villalobos","year":"2004","journal-title":"J Neurosci"},{"key":"10.1124\/molpharm.121.000478_bib28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nn1648","article-title":"Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia","volume":"9","author":"Walter","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1124\/molpharm.121.000478_bib29","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0896-6273(02)00733-X","article-title":"A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration","volume":"34","author":"Watase","year":"2002","journal-title":"Neuron"},{"key":"10.1124\/molpharm.121.000478_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4939-7362-0_9","article-title":"Thallium flux assay for measuring the activity of monovalent cation channels and transporters","volume":"1684","author":"Weaver","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1124\/molpharm.121.000478_bib31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/1087057104268749","article-title":"A thallium-sensitive, fluorescence-based assay for detecting and characterizing potassium channel modulators in mammalian cells","volume":"9","author":"Weaver","year":"2004","journal-title":"J Biomol Screen"},{"key":"10.1124\/molpharm.121.000478_bib32","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.neuroscience.2009.05.016","article-title":"Large conductance calcium-activated potassium channels affect both spontaneous firing and intracellular calcium concentration in cerebellar Purkinje neurons","volume":"162","author":"Womack","year":"2009","journal-title":"Neuroscience"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24012367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24012367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/molpharm.121.000478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:31:07Z","timestamp":1739957467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24012367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0026895X24012367"],"URL":"https:\/\/doi.org\/10.1124\/molpharm.121.000478","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of Novel Activators of Large-Conductance Calcium-Activated Potassium Channels for the Treatment of Cerebellar Ataxia","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/molpharm.121.000478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}